Woodstock Corp Ligand Pharmaceuticals Inc Transaction History

Woodstock Corp

$1.03 Billion
Q3 2024

A detailed history of Woodstock Corp transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Woodstock Corp holds 29,211 shares of LGND stock, worth $3.21 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

29,211

Previous 29,111 0.34%

Holding current value

$3.21 Million

Previous $2.45 Million 19.33%

% of portfolio

0.28%

Previous 0.25%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$82.7 - $110.11 $8,270 - $11,011	100 Added 0.34%	29,211 $2.93 Million
Q2 2024 Jul 08, 2024	SELL	$68.53 - $87.91 $68,530 - $87,910	-1,000 Reduced 3.32%	29,111 $2.45 Million
Q4 2023 Jan 08, 2024	SELL	$49.57 - $72.63 $200,708 - $294,078	-4,049 Reduced 11.85%	30,111 $2.15 Million
Q3 2023 Oct 10, 2023	SELL	$58.86 - $72.67 $743,696 - $918,185	-12,635 Reduced 27.0%	34,160 $2.05 Million
Q2 2023 Jul 07, 2023	SELL	$69.53 - $79.33 $403,899 - $460,827	-5,809 Reduced 11.04%	46,795 $3.37 Million
Q1 2023 Apr 06, 2023	SELL	$65.67 - $77.08 $158,264 - $185,762	-2,410 Reduced 4.38%	52,604 $3.87 Million
Q4 2022 Jan 10, 2023	SELL	$61.72 - $96.74 $412,289 - $646,223	-6,680 Reduced 10.83%	55,014 $0
Q3 2022 Oct 11, 2022	SELL	$0.01 - $107.56 $22 - $237,277	-2,206 Reduced 3.45%	61,694 $5.31 Million
Q2 2022 Jul 11, 2022	SELL	$74.52 - $117.06 $11,178 - $17,559	-150 Reduced 0.23%	63,900 $5.7 Million
Q1 2022 Apr 07, 2022	SELL	$94.99 - $151.56 $438,473 - $699,600	-4,616 Reduced 6.72%	64,050 $7.21 Million
Q3 2021 Oct 05, 2021	SELL	$102.33 - $144.73 $11,256 - $15,920	-110 Reduced 0.16%	68,666 $9.57 Million
Q1 2021 Apr 05, 2021	SELL	$99.52 - $215.83 $70,360 - $152,591	-707 Reduced 1.02%	68,776 $10.5 Million
Q4 2020 Jan 06, 2021	BUY	$80.55 - $106.05 $1,611 - $2,121	20 Added 0.03%	69,483 $6.91 Million
Q3 2020 Oct 02, 2020	SELL	$89.56 - $126.72 $130,757 - $185,011	-1,460 Reduced 2.06%	69,463 $6.62 Million
Q2 2020 Jul 07, 2020	BUY	$68.28 - $123.65 $7,237 - $13,106	106 Added 0.15%	70,923 $7.93 Million
Q1 2020 Apr 03, 2020	SELL	$63.37 - $107.88 $42,584 - $72,495	-672 Reduced 0.94%	70,817 $5.15 Million
Q4 2019 Jan 13, 2020	BUY	$96.94 - $113.59 $23,362 - $27,375	241 Added 0.34%	71,489 $7.46 Million
Q3 2019 Oct 02, 2019	BUY	$86.25 - $120.16 $5,606 - $7,810	65 Added 0.09%	71,248 $7.09 Million
Q2 2019 Jul 03, 2019	BUY	$107.38 - $129.34 $46,173 - $55,616	430 Added 0.61%	71,183 $8.13 Million
Q1 2019 Apr 05, 2019	BUY	$105.93 - $142.47 $105,294 - $141,615	994 Added 1.42%	70,753 $8.89 Million
Q4 2018 Jan 08, 2019	BUY	$128.36 - $272.13 $391,626 - $830,268	3,051 Added 4.57%	69,759 $9.47 Million
Q3 2018 Oct 03, 2018	SELL	$211.18 - $274.49 $250,881 - $326,094	-1,188 Reduced 1.75%	66,708 $18.3 Million
Q2 2018 Jul 23, 2018	SELL	$150.77 - $207.98 $162,077 - $223,578	-1,075 Reduced 1.56%	67,896 $14.1 Million
Q1 2018 Apr 19, 2018	SELL	$138.63 - $182.62 $24,537 - $32,323	-177 Reduced 0.26%	68,971 $11.4 Million
Q4 2017 Jan 24, 2018	BUY	$128.36 - $147.04 $27,340 - $31,319	213 Added 0.31%	69,148 $9.47 Million
Q3 2017 Oct 06, 2017	BUY	$120.91 - $137.94 $8.33 Million - $9.51 Million	68,935	68,935 $9.39 Million

Others Institutions Holding LGND

# of Institutions

249

Shares Held

17.6M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.86B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

News

Stay updated on Woodstock Corp with notifications on news.

Account